Literature DB >> 21542827

Impaired immune function in children with Fanconi anaemia.

Kasiani C Myers1, Jack J Bleesing, Stella M Davies, Xue Zhang, Lisa J Martin, Robin Mueller, Richard E Harris, Alexandra H Filipovich, Melinda B Kovacic, Susanne I Wells, Parinda A Mehta.   

Abstract

Fanconi anaemia is an autosomal recessive or X-linked disease characterized by progressive bone marrow failure, variable congenital abnormalities and a predisposition to malignancy. Reports of immune function in this population are limited, and include only specific areas of immune performance, showing variable defects. We report a cross-sectional immunological assessment in 10 children with FA. Absolute numbers of B cells and natural killer (NK) cells were reduced compared to controls (P = 0·048 and P = 0·0002, respectively), while absolute number of T cells were within normal range. Perforin and granzyme content of NK cells was reduced (P < 0·00001 and P = 0·0057, respectively) along with the NK cell cytotoxicity (P < 0·001). Antigen proliferation in response to tetanus was decreased (P = 0·008) while responses to candida and phytohaemagglutinin were not. Cytotoxic T cell function was also reduced (P < 0·0001). Immunoglobulin G levels were normal in those evaluated. Our series represents the first attempt at a comprehensive quantitative and functional evaluation of immune function in this rare group of patients and demonstrates a significant deficit in the NK cell compartment, a novel quantitative B cell defect, along with abnormal cytotoxic function. These findings may be especially relevant in this patient population with known predisposition to DNA damage and malignancy.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21542827      PMCID: PMC5922775          DOI: 10.1111/j.1365-2141.2011.08721.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  28 in total

1.  A hereditary immunodeficiency characterized by CD8+ T lymphocyte deficiency and impaired lymphocyte activation.

Authors:  W J Monafo; S H Polmar; S Neudorf; A Mather; A H Filipovich
Journal:  Clin Exp Immunol       Date:  1992-12       Impact factor: 4.330

2.  Physical and laboratory characteristics of heterozygote carriers of the Fanconi aplasia gene.

Authors:  M Petridou; A J Barrett
Journal:  Acta Paediatr Scand       Date:  1990-11

3.  Presence of hypogammaglobulinemia in a patient with Fanconi anemia: a case report.

Authors:  U N Sarwar; R Hamadeh
Journal:  J Investig Allergol Clin Immunol       Date:  2009       Impact factor: 4.333

Review 4.  Shwachman-Diamond syndrome.

Authors:  Yigal Dror
Journal:  Pediatr Blood Cancer       Date:  2005-12       Impact factor: 3.167

5.  Deficient natural killer cell activity in a patient with Fanconi's anaemia and squamous cell carcinoma. Association with defect in interferon release.

Authors:  P Hersey; A Edwards; R Lewis; A Kemp; J McInnes
Journal:  Clin Exp Immunol       Date:  1982-04       Impact factor: 4.330

6.  Phase 1 study of HPV16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIX adjuvant in women with cervical intraepithelial neoplasia.

Authors:  Ian H Frazer; Michael Quinn; Jim L Nicklin; Jeffrey Tan; Lew C Perrin; Peng Ng; Vivienne M O'Connor; Olivia White; Ngaire Wendt; Juliet Martin; Jayne M Crowley; Stirling J Edwards; Andrew W McKenzie; Susan V Mitchell; Darryl W Maher; Martin J Pearse; Russell L Basser
Journal:  Vaccine       Date:  2004-11-25       Impact factor: 3.641

7.  Tumor necrosis factor-alpha overproduction in Fanconi's anemia.

Authors:  J C Schultz; N T Shahidi
Journal:  Am J Hematol       Date:  1993-02       Impact factor: 10.047

8.  Head and neck squamous cell carcinoma in 13 patients with Fanconi anemia after hematopoietic stem cell transplantation.

Authors:  Caroline Masserot; Régis Peffault de Latour; Vanderson Rocha; Thierry Leblanc; Arnaud Rigolet; Francis Pascal; Anne Janin; Jean Soulier; Eliane Gluckman; Gérard Socié
Journal:  Cancer       Date:  2008-12-15       Impact factor: 6.860

9.  A 20-year perspective on the International Fanconi Anemia Registry (IFAR).

Authors:  David I Kutler; Bhuvanesh Singh; Jaya Satagopan; Sat Dev Batish; Marianne Berwick; Philip F Giampietro; Helmut Hanenberg; Arleen D Auerbach
Journal:  Blood       Date:  2002-09-26       Impact factor: 22.113

10.  Abnormal lymphokine production: a novel feature of the genetic disease Fanconi anemia. II. In vitro and in vivo spontaneous overproduction of tumor necrosis factor alpha.

Authors:  F Rosselli; J Sanceau; E Gluckman; J Wietzerbin; E Moustacchi
Journal:  Blood       Date:  1994-03-01       Impact factor: 22.113

View more
  22 in total

1.  Detection of human papillomavirus in the oral cavities of persons with Fanconi anemia.

Authors:  R L Winer; C E Huang; S Cherne; J E Stern; M S Butsch Kovacic; P A Mehta; S L Sauter; D A Galloway; R A Katzenellenbogen
Journal:  Oral Dis       Date:  2014-09-18       Impact factor: 3.511

2.  Cytokine production by bone marrow mononuclear cells in inherited bone marrow failure syndromes.

Authors:  Ken Matsui; Neelam Giri; Blanche P Alter; Ligia A Pinto
Journal:  Br J Haematol       Date:  2013-07-25       Impact factor: 6.998

3.  Deletion of Fanca or Fancd2 dysregulates Treg in mice.

Authors:  Wei Du; Ozlem Erden; Andrew Wilson; Jared M Sipple; Jonathan Schick; Parinda Mehta; Kasiani C Myers; Kris A Steinbrecher; Stella M Davies; Qishen Pang
Journal:  Blood       Date:  2014-02-05       Impact factor: 22.113

4.  Common Variable Immunodeficiency Caused by FANC Mutations.

Authors:  Yujin Sekinaka; Noriko Mitsuiki; Kohsuke Imai; Miharu Yabe; Hiromasa Yabe; Kanako Mitsui-Sekinaka; Kenichi Honma; Masatoshi Takagi; Ayako Arai; Kenichi Yoshida; Yusuke Okuno; Yuichi Shiraishi; Kenichi Chiba; Hiroko Tanaka; Satoru Miyano; Hideki Muramatsu; Seiji Kojima; Asuka Hira; Minoru Takata; Osamu Ohara; Seishi Ogawa; Tomohiro Morio; Shigeaki Nonoyama
Journal:  J Clin Immunol       Date:  2017-05-11       Impact factor: 8.317

5.  Immune status of patients with inherited bone marrow failure syndromes.

Authors:  Neelam Giri; Blanche P Alter; Keri Penrose; Roni T Falk; Yuanji Pan; Sharon A Savage; Marcus Williams; Troy J Kemp; Ligia A Pinto
Journal:  Am J Hematol       Date:  2015-05-28       Impact factor: 10.047

6.  Loss of Fancc Impairs Antibody-Secreting Cell Differentiation in Mice through Deregulating the Wnt Signaling Pathway.

Authors:  Mathieu Sertorio; Surya Amarachintha; Andrew Wilson; Qishen Pang
Journal:  J Immunol       Date:  2016-02-19       Impact factor: 5.422

7.  Antibody response to human papillomavirus vaccination and natural exposure in individuals with Fanconi Anemia.

Authors:  Parinda A Mehta; Sharon Sauter; Xue Zhang; Stella M Davies; Suzanne I Wells; Kasiani C Myers; Gitika Panicker; Elizabeth R Unger; Melinda Butsch Kovacic
Journal:  Vaccine       Date:  2017-10-16       Impact factor: 3.641

8.  Impaired immune function in children and adults with Fanconi anemia.

Authors:  Kasiani C Myers; Sharon Sauter; Xue Zhang; Jacob J Bleesing; Stella M Davies; Susanne I Wells; Parinda A Mehta; Ashish Kumar; Daniel Marmer; Rebecca Marsh; Darron Brown; Melinda Butsch Kovacic
Journal:  Pediatr Blood Cancer       Date:  2017-05-30       Impact factor: 3.167

9.  Oral human papillomavirus is common in individuals with Fanconi anemia.

Authors:  Sharon L Sauter; Susanne I Wells; Xue Zhang; Elizabeth E Hoskins; Stella M Davies; Kasiani C Myers; Robin Mueller; Gitika Panicker; Elizabeth R Unger; Umasundari Sivaprasad; Darron R Brown; Parinda A Mehta; Melinda Butsch Kovacic
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-03-25       Impact factor: 4.254

Review 10.  Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation.

Authors:  Andrew C Dietz; Parinda A Mehta; Adrianna Vlachos; Sharon A Savage; Dorine Bresters; Jakub Tolar; Farid Boulad; Jean Hugues Dalle; Carmem Bonfim; Josu de la Fuente; Christine N Duncan; K Scott Baker; Michael A Pulsipher; Jeffrey M Lipton; John E Wagner; Blanche P Alter
Journal:  Biol Blood Marrow Transplant       Date:  2017-01-20       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.